Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Germline mutations predisposing to melanoma
Beteiligte:
Toussi, Atrin;
Mans, Nicole;
Welborn, Jeanna;
Kiuru, Maija
Erschienen:
Wiley, 2020
Erschienen in:Journal of Cutaneous Pathology
Sprache:
Englisch
DOI:
10.1111/cup.13689
ISSN:
0303-6987;
1600-0560
Entstehung:
Anmerkungen:
Beschreibung:
<jats:title>Abstract</jats:title><jats:p>Nearly 15% of melanomas occur in patients with a family history and a subset of these patients have a germline mutation in a melanoma predisposing gene. <jats:italic>CDKN2A</jats:italic> mutations are responsible for the majority of hereditary melanoma, but many other susceptibility genes have been discovered in recent years, including <jats:italic>CDK4</jats:italic>, <jats:italic>TERT</jats:italic>, <jats:italic>ACD</jats:italic>, <jats:italic>TERF2IP</jats:italic>, <jats:italic>POT1</jats:italic>, <jats:italic>MITF</jats:italic>, <jats:italic>MC1R</jats:italic>, and <jats:italic>BAP1</jats:italic>. Additionally, melanoma risk is increased in mixed cancer syndromes caused by mutations in <jats:italic>PTEN</jats:italic>, <jats:italic>BRCA2</jats:italic>, <jats:italic>BRCA1</jats:italic>, <jats:italic>RB1</jats:italic>, and <jats:italic>TP53</jats:italic>. While early onset, multiple tumors, and family cancer history remain the most valuable clinical clues for hereditary melanoma, characteristic epithelioid cytology of melanocytic tumors may suggest an underlying <jats:italic>BAP1</jats:italic> mutation. Herein, we review the clinical and histopathologic characteristics of melanocytic tumors associated with these germline mutations and discuss the role of genetic counseling.</jats:p>